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Background Results
• Cancer is the second leading cause of death globally;
therefore, the continuous development of new, more
effective treatments is vital in the effort to reduce
cancer deaths [1]
• The genetic makeup of an individual has been shown
to affect the way in which their body responds to a
given drug, meaning it is difficult to create a single
treatment that will work for every patient [2]
• Lymphoblastoid cell lines (LCLs) are widely available
across ethnic cohorts and constitute an effective
model for measuring drug response in an individual [2]
• Genome-wide association studies (GWAS) can
identify relationships between single nucleotide
polymorphisms (SNPs) and phenotypes [3, 4]
• The majority of GWAS have been on individuals with
European ancestries, but in order to develop
personalized treatments other ancestries must be
represented [5]
• Transcriptome-wide association studies (TWAS) aid in
contextualizing the SNPs identified in GWAS as they
estimate the level to which a gene is expressed,
something not computed in GWAS [6]
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• Six genome-wide significant SNPS on chromosome
12 were found to be associated with Etoposide
cytotoxicity in YRI
• Two genome-wide significant SNPs on chromosome 4
were found to be associated with Daunorubicin
cytotoxicity in YRI
• Three genome-wide significant SNPS on chromosome
9 were found to be significantly associated with
Carboplatin in ASN
• Two genome-wide significant SNPS on chromosome
12 were found to be significantly associated with
Etoposide in ALL
• High predicted expression of STARD5 in the Brain
Cortex was found to be significantly associated with
cellular sensitivity to Etoposide in ALL (p = 8.5e-08)
• High predicted expression of USF1 in the Liver was
found to be significantly associated with cellular
resistance to Capecitabine in ALL (p = 8.7e-08)
Three populations: Yoruba from 
Nigeria (YRI), European Ancestries 
from Utah, and Japanese from Tokyo 
and Han Chinese from Beijing (ASN)
Eight Chemotherapy Drugs: Ara-C, 
Capecitabine, Carboplatin, Cisplatin, 
Daunorubicin, Etoposide, Paclitaxel, 
and Pemetrexed
Figure 2: QQ plot of 
GWAS results for 
Etoposide in YRI. 
Six genome-wide 
significant SNPs 
were identified:
• rs7971310
• rs7960974
• rs7979399
• rs2711729
• rs2711728
• rs11183699
Figure 3: Manhattan
plot of GWAS results 
for Etoposide in YRI. 
The red line indicates 
the genome-wide 
significance threshold. 
Six SNPs located on 
chromosome twelve 
met this threshold: 
(p < 5e-08)
Figure 4: Predicted expression plot of STARD5
predicted expression in the Brain Cortex vs Etoposide 
concentration in ALL. As STARD5 expression 
decreases, the concentration of Etoposide needed for 
cytotoxicity increases.
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Figure 1: Overview of methods.
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